210 related articles for article (PubMed ID: 35606704)
1. Intestinal fatty acid binding protein is a disease biomarker in paediatric coeliac disease and Crohn's disease.
Logan M; MacKinder M; Clark CM; Kountouri A; Jere M; Ijaz UZ; Hansen R; McGrogan P; Russell RK; Gerasimidis K
BMC Gastroenterol; 2022 May; 22(1):260. PubMed ID: 35606704
[TBL] [Abstract][Full Text] [Related]
2. Dietary triggers of gut inflammation following exclusive enteral nutrition in children with Crohn's disease: a pilot study.
Gkikas K; Logan M; Nichols B; Ijaz UZ; Clark CM; Svolos V; Gervais L; Duncan H; Garrick V; Curtis L; Buchanan E; Cardigan T; Armstrong L; Delahunty C; Flynn DM; Barclay AR; Tayler R; Milling S; Hansen R; Russell RK; Gerasimidis K
BMC Gastroenterol; 2021 Dec; 21(1):454. PubMed ID: 34861829
[TBL] [Abstract][Full Text] [Related]
3. Risk of schizophrenia in people with coeliac disease, ulcerative colitis and Crohn's disease: a general population-based study.
West J; Logan RF; Hubbard RB; Card TR
Aliment Pharmacol Ther; 2006 Jan; 23(1):71-4. PubMed ID: 16393282
[TBL] [Abstract][Full Text] [Related]
4. Plasma levels of endothelin-1 in patients with Crohn's disease and ulcerative colitis.
Letizia C; Boirivant M; De Toma G; Cerci S; Subioli S; Scuro L; Ferrari P; Pallone F
Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):266-9. PubMed ID: 9759593
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of plasma Short chain fatty acid levels as markers for Inflammatory bowel disease.
Kiasat A; Rautiainen S; Prast-Nielsen S; Engstrand L; Schuppe-Koistinen I; Gustafsson UO; Löf Granström A
Scand J Gastroenterol; 2023; 58(11):1246-1252. PubMed ID: 37272725
[TBL] [Abstract][Full Text] [Related]
6. Cancer in patients with ulcerative colitis, Crohn's disease and coeliac disease: record linkage study.
Goldacre MJ; Wotton CJ; Yeates D; Seagroatt V; Jewell D
Eur J Gastroenterol Hepatol; 2008 Apr; 20(4):297-304. PubMed ID: 18334873
[TBL] [Abstract][Full Text] [Related]
7. Inflammation-related Proteins Support Diagnosis of Inflammatory Bowel Disease and Are Modified by Exclusive Enteral Nutrition in Children With Crohn's Disease, Especially of Ileal Phenotype.
White B; Svolos V; Gervais L; Jatkowska A; Nichols B; MacDonald J; Seenan JP; Hansen R; Russell RK; Milling S; Gerasimidis K
Inflamm Bowel Dis; 2024 Jun; ():. PubMed ID: 38920313
[TBL] [Abstract][Full Text] [Related]
8. Exclusive enteral nutrition with concomitant early thiopurine use was effective in maintaining steroid-free remission in a Southeast Asian cohort of children with Crohn's disease.
Ong C; Lim PT; Logarajah V; Liwanag MJ; Ang BX; Cher Y; Chiou FK; Kader A
BMC Gastroenterol; 2018 Dec; 18(1):185. PubMed ID: 30541458
[TBL] [Abstract][Full Text] [Related]
9. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease.
Daig R; Andus T; Aschenbrenner E; Falk W; Schölmerich J; Gross V
Gut; 1996 Feb; 38(2):216-22. PubMed ID: 8801200
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to maize in patients with Crohn's disease, ulcerative colitis and coeliac disease.
Davidson IW; Lloyd RS; Whorwell PJ; Wright R
Clin Exp Immunol; 1979 Jan; 35(1):147-8. PubMed ID: 371884
[TBL] [Abstract][Full Text] [Related]
11. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
12. INTERACTIONS AMONG INTERLEUKIN-6, C-REACTIVE PROTEIN AND INTERLEUKIN-6 (-174) G/C POLYMORPHISM IN THE PATHOGENESIS OF CROHN'S DISEASE AND ULCERATIVE COLITIS.
Takač B; Mihaljević S; Glavaš-Obrovac L; Kibel A; Suver-Stević M; Canecki-Varžić S; Samardžija M; Rajkovac I; Kovač D; Štefanić M
Acta Clin Croat; 2020 Mar; 59(1):67-80. PubMed ID: 32724277
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their possible pathogenic importance.
Giaffer MH; Clark A; Holdsworth CD
Gut; 1992 Aug; 33(8):1071-5. PubMed ID: 1398231
[TBL] [Abstract][Full Text] [Related]
14. A study evaluating the bidirectional relationship between inflammatory bowel disease and self-reported non-celiac gluten sensitivity.
Aziz I; Branchi F; Pearson K; Priest J; Sanders DS
Inflamm Bowel Dis; 2015 Apr; 21(4):847-53. PubMed ID: 25719528
[TBL] [Abstract][Full Text] [Related]
15. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease.
Satsangi J; Welsh KI; Bunce M; Julier C; Farrant JM; Bell JI; Jewell DP
Lancet; 1996 May; 347(9010):1212-7. PubMed ID: 8622450
[TBL] [Abstract][Full Text] [Related]
16. Clinical features and oncological outcomes of intestinal cancers associated with ulcerative colitis and Crohn's disease.
Noguchi T; Ishihara S; Uchino M; Ikeuchi H; Okabayashi K; Futami K; Tanaka S; Ohge H; Nagahara H; Watanabe K; Itabashi M; Okamoto K; Okita Y; Mizushima T; Mizuuchi Y; Yamada K; Shimada Y; Sato Y; Kimura H; Takahashi K; Hida K; Kinugasa Y; Okuda J; Daito K; Koyama F; Ueno H; Yamamoto T; Hanai T; Maemoto A; Oba K; Ajioka Y; Sugihara K;
J Gastroenterol; 2023 Jan; 58(1):14-24. PubMed ID: 36182971
[TBL] [Abstract][Full Text] [Related]
17. Investigation of IL23R, JAK2, and STAT3 gene polymorphisms and gene-gene interactions in Crohn's disease and ulcerative colitis in a Turkish population.
Can G; Tezel A; Gürkan H; Tozkır H; Ünsal G; Soylu AR; Ümit HC
Turk J Gastroenterol; 2016 Nov; 27(6):525-536. PubMed ID: 27852544
[TBL] [Abstract][Full Text] [Related]
18. Repeated exclusive enteral nutrition in the treatment of paediatric Crohn's disease: predictors of efficacy and outcome.
Frivolt K; Schwerd T; Werkstetter KJ; Schwarzer A; Schatz SB; Bufler P; Koletzko S
Aliment Pharmacol Ther; 2014 Jun; 39(12):1398-407. PubMed ID: 24779671
[TBL] [Abstract][Full Text] [Related]
19. Is measles vaccination a risk factor for inflammatory bowel disease?
Thompson NP; Montgomery SM; Pounder RE; Wakefield AJ
Lancet; 1995 Apr; 345(8957):1071-4. PubMed ID: 7715338
[TBL] [Abstract][Full Text] [Related]
20. A case for improved assessment of gut permeability: a meta-analysis quantifying the lactulose:mannitol ratio in coeliac and Crohn's disease.
Gan J; Nazarian S; Teare J; Darzi A; Ashrafian H; Thompson AJ
BMC Gastroenterol; 2022 Jan; 22(1):16. PubMed ID: 35012471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
